Table 2.
The apoptotic rate of corpus striatum, SDH, and DRG
| Groups | Apoptotic rate (%)
|
||
|---|---|---|---|
| Corpus striatum | SDH | DRG | |
|
| |||
| C | 12% | 8% | 11% |
| P | 44% | 49% | 45% |
| R | 7% | 7% | 9% |
| R+P | 31% | 33% | 28% |
| E | 42% | 45% | 41% |
Notes: Group C was the control rats; Group P was paclitaxel-treated rats; Group R received RES treatment; Group R+P was treated with paclitaxel with the pretreatment of RES; Group E underwent paclitaxel treatment with the pretreatment of RES and EX-527.
Abbreviations: C, control group; R, resveratrol group; P, paclitaxel-treated group; R+P, resveratrol + paclitaxel-treated group; DRG, dorsal root ganglions; RES, resveratrol; SDH, spinal dorsal horns; E, pretreated-resveratrol + pretreated-paclitaxel + EX-527 group.